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Abstract.  Anti-Sm antibodies recognize a group of 
small, nuclear RNA-protein complexes (snRNPs) 
containing U 1, U2, U4, U5, and U6 snRNAs. Anti- 
RNP antibodies only react with U I snRNA-contain- 
ing complexes. 
The intranuclear distribution of snRNP particles 
was studied by double immunofluorescence staining 
of human fibroblasts. Mouse monoclonal anti-Sm an- 
tibodies and polyclonal patient sera reacting with dif- 
ferent peptides in the snRNP complexes were used. 
The immunofluorescence patterns obtained with fluo- 
rescein isothiocyanate-conjugated  anti-mouse Ig and 
tetramethylrhodamine isothiocyanate-conjugated 
anti-human Ig second antibodies were examined us- 
ing computer analysis of digitized images. With this 
approach the similarity of different patterns could be 
visualized and estimated with mathematical methods. 
It was found that human anti-Sm serum as well as 
three different anti-RNP sera produced speckled pat- 
terns overlapping with the anti-Sm monoclonal pat- 
tern. Thus, Sm antigenic intranuclear domains also 
reacted with anti-RNP antibodies, suggesting a high 
degree of co-localization of the antigenic structures. A 
partial overlap was found between speckles detected 
by mouse anti-Sm antibodies and a human La-anti- 
serum. No significant co-localization occurred be- 
tween speckles detected by mouse anti-Sm antibodies 
and speckles detected by human antisera reacting with 
Scl-70 and centromeric antigens. 
As the U 1 snRNP complex is believed to play a role 
in the splicing of RNA polymerase II transcripts, it 
appears that the speckles detected by Sm and RNP 
antibodies may be regions of hnRNA synthesis and 
m.RNA processing. Although no function has been 
demonstrated for the U2, U4, U5, and U6 snRNPs, 
the co-localization with the U 1 RNA complexes 
shown in this report indicate that they too participate 
in some aspect of mRNA processing. The results sug- 
gest that computer-assisted analysis of nuclear immu- 
nofluorescence patterns will be a useful tool in studies 
of the spatial and functional organization of the inter- 
phase nucleus. 
I 
MMUNE staining of mammalian cells with autoimmune 
sera frequently results in a speckled nuclear pattern. The 
two major specificities  that produce speckled patterns are 
known as Sm and RNP. These autoantibodies occur primarily 
in  systemic lupus  erythematosus,  mixed  connective tissue 
disease, and less frequently in other autoimmune diseases (3, 
31, 35). 
The Sm and RNP antigenic structures are thus concentrated 
in certain nuclear domains. Immunochemical and biochem- 
ical studies have elucidated the nature of  the antigens (1, 11- 
13, 16,  18, 20, 25, 33, 34, 37, 38). Sm-antibodies were shown 
to immunoprecipitate RNA-protein complexes containing a 
class of small nuclear RNAs designated U l, U2, U4, U5, and 
U6 snRNAs) RNP-antibodies, on the other hand, immuno- 
precipitated only U 1 RNA-containing complexes (18). Pro- 
teins were required for antigenicity (18). The fact that small, 
U3 is nucleolar  and not precipitated  by Sm/RNP antibodies. 
nuclear RNA-protein complex (snRNP)  2  particles containing 
only U l RNA can be immunoprecipitated separately by RNP 
antibodies,  suggest that  the  U l  snRNP  particles are  not 
strongly associated with the other snRNPs. The report of an 
anti-U2 snRNP antiserum allows the same conclusion to be 
made concerning the U2 snRNPs (20). In the case of U4 and 
U6, it has been shown that, most likely, they form a distinct 
complex (4,  9).  Furthermore,  it is possible to separate the 
snRNP  particles by gradient centrifugation of cell extracts, 
indicating that the U l, U2, U4-U6, and U5 RNAs are present 
as distinct, stable RNA-protein  complexes and not as firmly 
integrated subunits of a large multi-snRNA complex (16). 
However, using low ionic strength buffers they can be found 
to co-migrate with hnRNP particles in gradients (30, 32, 39). 
By immunoprecipitation  of 35S-labeled cell extracts it  has 
2  Abbreviations  used in Ibis paper." FITC, fluorescein  isothiocyanate;  snRNP, 
small, nuclear RNA-protein complexes; TRITC, tetramethylrhodamine  iso- 
thiocyanate. 
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nine polypeptides denoted A-G (18). Two additional proteins 
were subsequently identified  and named A'  and 68K (11). 
Some seem to be common to all the particles, like B/B' and 
D. Others are restricted to individual complexes.  The 68K, 
A, and C proteins are specific for U 1 RNA-containing parti- 
cles. At least one U2-specific polypeptide, A', has been found 
(13, 20). Proteins uniquely associated with the other particles 
have not been reproducibly demonstrated. In summary, judg- 
ing  from  studies  of cell  extracts,  RNP-sera  recognize  one 
distinct  U1  snRNP  complex,  and  Sm  sera  recognize four 
different complexes, the U l,  U2,  U4/U6,  and U5  snRNPs. 
In situ in the nucleus, they are restricted to certain regions, 
giving rise to the speckled immunofluorescence seen with Sm 
and RNP sera. 
A  distinguishing feature of the snRNA family is the pres- 
ence of a 5'-terminal 2, 2, 7-trimethylguanosine cap structure. 
Antibodies prepared against this structure produced the same 
type of speckled nuclear immunofluorescence patterns as did 
the Sm and RNP antibodies (26). 
Evidence concerning the biological function of snRNPs is 
more circumstantial.  Consistent  observations indicate  that 
some members of this class play a role in the processing of 
polymerase II transcripts. U l-snRNPs are thought to partici- 
pate in  hnRNA  splicing  (14,  16,  23,  24),  and U4  snRNPs 
could be involved in polyadenylation (2, 21). Taken together 
these observations suggest that the speckles seen with Sm and 
RNP  antibodies represent transcript-processing nuclear do- 
mains,  possibly  in  connection  with  hnRNA  transcription. 
Such a connection has been demonstrated in the Chironomus 
tentans  system  by  Sass  et  al.  (29).  Transcriptionally active 
regions in the salivary gland polytene chromosomes of Chi- 
ronomus tentans larvae were shown to react strongly with Sm 
and RNP antibodies. 
As  several  different  snRNP  complexes  exist,  interesting 
questions  are  whether  all  the  snRNA  species  and  all  the 
antigens detected by Sm and RNP antisera are present in the 
same intranuclear domains, and what the fate of these struc- 
tures is during the cell cycle. To approach such questions we 
have  combined  the  use  of well-characterized antisera with 
computer-aided image analysis of immunofluorescence pat- 
terns. The results obtained by immune staining with Sm and 
RNP  antibodies  have  been  compared  with  those  obtained 
with antisera directed against the La (3,  31,  35),  the Scl-70 
(5), and centromeric antigens (22, 35). 
Materials and Methods 
Cells 
Human  fibroblasts of the 253/79  strain were kindly provided by Dr Stefan 
Srderhall, Department of Clinical Genetics, Karolinska Hospital, Stockholm, 
and cultured on  Dulbecco's modified Eagle's medium containing  10%  fetal 
calf serum,  streptomycin,  and  penicillin. The  cells were  seeded  on  Biarker 
hemocytometer slides, grown until subconfluent, and then used for immuno- 
fluorescence studies. Jurkat cells, a human T-cell leukemia line, were cultured 
on  RPMI  1640  medium containing 5%  fetal calf serum, streptomycin, and 
penicillin. 
Antisera and Monoclonal Antibodies 
All but one of the human sera used in this study were selected among a large 
number  of autoimmune  sera  from  the  University of  Missouri,  Columbia 
(UMC). The patients had had serial clinical and serological evaluations. The 
UMC-ANA Laboratory profile included hemagglutination tests for antibodies 
to extractable nuclear antigen and DNA.  immunodiffusion test for antibodies 
to RNP, Sm (Table I), La (SS-B),  Ro (SS-A),  Scl 70, and Pro-l; and Crithidia 
luciliae testing for antibodies to native DNA. Only Sm antibodies were detected 
in serum TA; sera CL, RE, and AL had only RNP antibodies; serum HA was 
positive only for antibodies to  La-antigen; serum  PE  was positive only for 
antibodies to Scl-70. Analyses of snRNAs in immunoprecipitates and immu- 
noblotting were finally used to rigorously define these sera as reacting specifi- 
cally with certain RNAs and peptides as summarized in Table II. Serum LU 
was from a Stockholm CREST patient who had anti-centromere antibodies as 
judged by the fluorescent ANA test. The mouse anti-Sin hybridoma Y I2 was 
kindly provided by Dr Joan Steitz, Yale University, New Haven, CT (17). 
Analysis of lmmunoprecipitated RNA 
Immunoprecipitation, RNA extraction, and electrophoresis were carried out 
essentially as described (11,  18).  The  modifications involve the amounts  of 
serum and cell extract as unlabeled cells were used in these experiments. For 
each immunoprecipitate, 20 ~1 of serum and a Jurkat cell extract corresponding 
to 5 x  ~0  7 cells was used. 
Deteetion of  Peptide Antigens by Immunoblotting 
Jurkat cells were dissolved in SDS gel sample buffer, boiled for  10 min, and 
then electrophoresed on  15% SDS polyacrylamide gels according to Laemmli 
(15).  The amount loaded corresponds to  1 ×  10  6 cells/mm slot width. After 
separation, the peptides were transferred to  Trans-Blot  nitrocellulose sheets 
(Bio-Rad Laboratories, Richmond, CA) by electroblotting for 2  h at 225  mA 
in a  buffer containing 25  mM  Tris,  192  mM  gtycine, 0.1%  SDS,  and 25% 
methanol (20, 36). 
The nitrocellulose filters were then blocked by incubating overnight in a 
0.1%  ovalbumin solution. After rinsing in PBS,  0.05%  Tween-20, the filters 
were probed for the presence of antigenic peptides by incubating with patient 
sera diluted 1/250 or  1/400 (LU serum) in PBS-Tween. The anti-Sm mono- 
clonal was diluted l/100. The binding of these antibodies was detected using 
horseradish peroxidase conjugated anti-mouse lg or anti-human IgG second 
antibodies (Dakopatts AS, Glostrup, Denmark) with 4-chloro-l-naphtol as the 
substrate (8). 
Double Immunofluorescence Staining 
The  human  fibroblasts were chosen because of their extreme flatness, a  fact 
that greatly facilitated fluorescence microscopy. Slides with exponentially  grow- 
ing human fibroblasts of the 253/79 strain were rinsed in PBS and fixed in l:l 
acetone/ethanol at room temperature.  Before staining, the slides were rehy- 
drated  in  PBS,  blocked with a  I%  solution of ovalbumin, and rinsed three 
times in PBS.  The preparations were then reacted with a  mixture of mouse 
monoclonal anti-Sm antibodies, diluted l: 100, and human antisera. The latter 
were diluted 1:250 except the LU anticentromeric antiserum which was diluted 
1:400.  Staining was carried out for 40 rain at 37"C,  followed by three washes 
in PBS at room temperature.  Incubation with second antibodies was carried 
out in two successive 20-min steps at room temperature. First the preparations 
were incubated with fluorescein isothiocyanate (FITC)-conjugated anti-mouse 
Ig antibodies (Dakopatts) diluted 1:20.  After washing three times in PBS,  the 
cells were then stained with tetramethylrhodamine isothiocyanate (TRITC)- 
conjugated antihuman-lgG antibodies (Dakopatts) diluted 1:20. This antibody 
had been absorbed with normal mouse serum. The slides were finally mounted 
in p-phenylendiamin in 9:1 glycerol/PBS. 
Controls were done to detect cross-reactivities and nonspecific staining. To 
exclude the  possibility of competitive antibody binding, the first antibodies 
were added in either order or mixed together, no detectable differences could 
be seen. After reacting with mouse or human first antibodies the preparations 
were incubated with inappropriate second antibodies. Other tests were made 
by omitting the first antibody and only staining with second antibodies. The 
results of these control experiments showed that the procedure used allowed 
accurate and simultaneous identification of the binding of mouse and human 
antibodies. 
Digital Image Analysis 
A detailed description of this procedure is given by Hallman et al. (manuscript 
in preparation). In short, the immune stained preparations were examined in 
a  Zeiss fluorescence microscope (Carl Zeiss, Inc., Thornwood,  NY)  using a 
100x oil immersion objective. A  silicon intensifier target video camera was 
used to register the image and to transfer it to a Zeiss/Kontron IBAS computer. 
Using filters, two images, one representing the FITC and one representing the 
TRITC-conjugated antibody, were recorded. Control experiments established 
that the filters did not allow leakage of emitted light from one fluorochrome 
into the image recorded for the other.  After recording a  binary image repre- 
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for the second fluorochrome. Lateral displacements between the first and the 
second image due to the switch of filters on the microscope were corrected for. 
Subsequently, the two binary patterns were assigned different gray levels and 
added together. Overlapping image components would then have a different 
gray level  from the original  patterns. The visualization of the differences in 
gray levels was facilitated  by the use of the pseudocolor feature of the instru- 
ment. The size and position of speckles as well as the degree of overlap between 
FITC and TRITC speckles was then recorded. 
The number of nuclei and nuclear speckles analyzed per sample is indicated 
in Figs. 7 and 8. 
Results 
Specificity of the Antisera 
Fig.  1 shows the  RNAs found in immunoprecipitates using 
the  mouse  monoclonal  Sm  antibody  Y l2  and  a  number 
ofhuman autoantisera. Serum TA is a polyclonal patient anti- 
Sm serum, and CL, AL, and RE are human anti-RNP sera 
as defined by RNase digestions,  hemagglutination, and im- 
munodiffusion tests (Table I). The mouse and human anti- 
Sm  immune  precipitates  (lanes  I  and  2)  contain  all  five 
snRNAs,  i.e.,  UI,  U2,  U4,  U5,  and  U6,  whereas the anti- 
RNP  precipitates contain  only Ul  RNA  (lanes  3-5).  The 
band  seen just  below  UI  is  a  slightly  shorter  breakdown 
product designated  U l*  in  previous publications (16).  The 
anti-La serum (lane 6) immunoprecipitated a  heterogenous 
mixture of small RNAs, which have been shown to consist of 
early RNA polymerase III transcripts (10,  27).  La immuno- 
precipitates also contain a small amount of U l RNA (10,  19). 
The PE antiserum, lane  7, directed against the Scl-70  (5) 
Figure  1  Polyacrylamide  gel  fractionation  of immunoprecipitated 
RNAs. Precipitates were obtained using an extract from a human cell 
line, Jurkat, and antibodies from a  mouse anti-SM hybridoma Yl2 
(lane 1), human autoimmune sera (lanes 2-8), and a  normal human 
serum (lane 9).  The following autoimmune specificities were repre- 
sented: anti-Sin serum, TA (lane 2), anti-RNP sera, CL (lane 3), RE 
(lane 4), AL (lane 5), anti-La serum, HA (lane 6), anti-scl 70 serum, 
PE (lane 7), and anti-centromere serum, LU (lane 8). 
Table L  Results of  Hemagglutination and Immune Diffu- 
sion Assays 
Extractable  nuclear antigen  Immunodiffusion 
Sera  HA liter  RNase result  RNP  Sm 
RE  1:10,000  Sensitive  +  0 
AL  1:10,000  Sensitive  +  0 
CL  1:100,000  Sensitive  +  0 
TA  1:10,000  Resistant  0  + 
For a discussion of these techniques, see reference 31. 
antigen and normal human control sera, lane 9, bring down 
traces of U 1 RNA and 5S RNA which represent nonspecific 
binding to the protein-A Sepharose immunoadsorbent. The 
LU immunoprecipitate shown in  lane 8  contains some U I 
RNA, the two small ribosomal RNA species 5S and 5.8S, and 
a smear with some clear bands included in the upper part of 
the gel. This pattern indicates that the anti-centromere sera 
also contain antibodies to ribosomes (17). 
Fig.  2  illustrates the  results  obtained  in  immunoblotting 
experiments with  the  antisera  listed  in  Table  II.  The  Sm 
monoclonal and the anti-Sm serum react with snRNP poly- 
peptides  B/B'  and  D  (lanes  1  and  2)  in  accordance  with 
previously published  results (20,  25).  The  three  anti-RNP 
sera react with different combinations of the  U 1-associated 
snRNP polypeptides: CL with a  68K protein  (lane 3),  RE 
with B/B' and faintly with C (lane 4), and AL with A (lane 
5)  (20,  25).  The  La  antiserum  (lane  6)  identifies  a  50K 
polypeptide (6, 7) which penetrates the nitrocellulose and thus 
stains more strongly on the backside of the sheet. The front 
side is shown here to demonstrate the absence of reactivity 
against the Sm or RNP specific peptides. 
The scl-70 antiserum (lane 7) did not react with any of the 
peptides  normally  present  in  snRNP  complexes.  The  LU 
antiserum (lane 8) reacted strongly with an  18K polypeptide 
associated with centromere regions (Hadlaczky, G.,  and  N. 
R. Ringertz, manuscript in preparation). The normal human 
control serum (lane 9) gives a weak background staining with 
histones. This background reactivity is present to a  varying 
extent in different patient antisera. 
The use of both immunoblotting and immunoprecipitation 
has confirmed the specificities assigned by other methods. It 
has also extended the previous analysis in two aspects impor- 
tant for this study: Firstly, most patient sera designated anti- 
Sm are actually mixed anti-Sm/anti-RNP (25).  The B/B' + 
D blotting pattern of serum TA demonstrates that it is a pure 
anti-Sm antisera.  No reactivity is detected against peptides 
68K, A, or C which are typically seen with RNP or Sm/RNP 
sera. Secondly, although  all RNP sera by definition immu- 
noprecipitate complexes containing U1  RNA,  they contain 
antibodies  reacting  with  different  polypeptides  in  the  U I 
RNA-protein complex. 
Immunofluorescence Patterns 
Figs. 3-6 illustrate the immunofluorescence patterns obtained 
with the anti-Sin and anti-RNP antisera and with antisera to 
other nuclear antigens that do not involve snRNA-protein 
complexes. For each human autoantibody an internal stand- 
ard was provided by the mouse monoclonal anti-Sm antibody 
using double immune staining as described in the Materials 
and Methods section. 
To obtain the pictures, the fluorescent patterns were con- 
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gel-fractionated  Jurkat proteins. A mouse monoclo- 
hal, human autoimmune sera, and normal human 
sera were  used.  The snRNP proteins are denoted 
with the nomenclature of reference  25. The nitro- 
cellulose  strips with the transferred proteins were 
reacted with the following antibodies: The mouse 
anti-Sm monoclonal Y I2 (strip 1), anti-Sm serum 
TA (strip 2), anti-RNP sera CL (strip 3), RE (strip 
4), AL (strip 5), anti-La serum HA (strip 6), anti- 
Scl-70 sera PE (strip 7), anti-centromere sera LU 
(strip 8), and normal human serum (strip 9). 
Table  II.  Summary of  Antibody SpeciJicities 
Immunoblot 
Disease or  Major RNA in ira-  peptide reac- 
Specificity/antibody  strain  munoprecipitation  tivity 
Anti-Sm 
YI2 mouse  MRL/lpr  UI, U2, U4, U5,  B/B', D 
monoclonal  strain  U6 
TA  SLE  U1, U2, U4, U5,  B/B', D 
U6 
Anti-RNP (68K+) 
CL  MCTD  U 1  68K 
Anti-RNP (68K-) 
RE  MCTD  U 1  B/B', C 
AL  SLE  U 1  A 
Anti-La 
HA  Sjrgrens  UI, 5S, and 4.5S  50K 
syndrome  smear 
Anti-Scl-70 
PE  PSS  --  -- 
Anti-centromere 
LU  CREST  5.8S, U1, 5S  18K 
SLE, systemic lupus erythematosus; MCTD, mixed connective tissue disease; 
PSS, progressive systemic  sclerosis or seleroderma; CREST, form ofscleroderma 
characterized by calcinosis,  Raynaud's phenomenon, esophageal dysmotility 
sclerodactyly  and teleangiectasia  (3, 31, 35). Patient sera are indicated by two 
capital  letters. 
verted to  a  digital image, displayed on  a  TV-monitor,  and 
photographed.  Note  that  the  quality  of the  photographed 
image is limited by the monitor. In the left hand panels, the 
nuclear fluorescence is shown  as recorded. The speckles are 
seen with diffuse borders embedded in a haze. 
The images shown in the right hand panels are generated 
in the computer by a  background-dependent gray level dis- 
crimination followed by a  filtering procedure. As a result the 
haze and very small speckles are removed and in the subse- 
quent image the speckles are presented as sharp bright spots 
against a dark background. 
Fig. 3  shows the patterns obtained with the human  anti- 
Sm serum and the mouse monoclonal anti-Sm. The similarity 
is obvious. The monoclonal anti-Sm versus human anti-Sm 
comparison provides the  reference for overlapping patterns 
that are interpreted as co-localization  of  the antigens. As anti- 
RNP sera only immunoprecipitate one of the anti-Sm reac- 
tive complexes it was conceivable that correspondingly only 
a  subgroup  of Sm  speckles  would  also  contain  the  RNP 
antigen.  On  the contrary, the speckles seen with  anti-RNP 
serum CL also agreed very well with those obtained with the 
mouse anti-Sm monoclonal (Fig. 4).  The same results were 
obtained with the two other RNP sera (images not shown). 
Thus all Sm-reactive regions also contained the RNP antigen. 
In terms of the intranuclear distribution of the snRNP com- 
plexes this implies that the Sm-reactive U2, U4, U5, and U6 
RNA-protein complexes are  localized in  the  same  nuclear 
domains  as  the  Sm-  and  RNP-reactive  U1  RNA-protein 
complexes. 
Striking  differences  in  the  distribution  of speckles  were 
found when the La-antiserum (Fig. 5) and the anticentromeric 
serum (Fig. 6) were compared with the mouse anti-Sm mono- 
clonal.  Although  the  former  sera  also  produced  speckled 
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antibodies  were identified  with  FITC- and TRITC-conjugated  second  antibodies,  respectively. The fluorescence was  recorded for both 
fluorochromes and converted into digital images by an IBAS computer. To obtain the pictures, the images were displayed on a TV-monitor 
and photographed. Left panel, unedited image. Right panel, image after gray level discrimination and filtering. Bar, 10 urn. (Fig. 3, upper left) 
Anti-Sm antiserum TA and mouse anti-Sin monoclonal; (Fig. 4, lower left) anti-RNP antiserum CL and mouse anti-Sm monoclonal; (Fig. 
5, upper right) anti-La antiserum HA and mouse anti-Sm monoclonal; (Fig. 6, lower right) anti-centromere antiserum LU and mouse anti- 
Sm monoclonal. 
nuclear immunofluorescence  patterns, the speckles were dif- 
ferently distributed from those observed with anti-Sm and 
anti-RNP sera.  It  should be  pointed out,  however,  that  a 
certain overlap exists between the patterns produced by the 
La antiserum and the mouse anti-Sm monoclonal. This is 
partly due  to  the  fact  that  the  La  antigen is  more  evenly 
141  Nyman et al. Intranuclear Localization of  snRNP Antigens distributed, whereas the mouse anti-Sin antibodies produce 
relatively well-defined speckles. The anti-centromeric serum 
produced very distinct speckles that showed a lower degree of 
overlap with  Sm-speckles than  did  any  of the  other  non- 
snRNP antisera. 
The degree of overlap between anti-Sm and anti-RNP sera 
on the one hand, and the non-overlap of mouse anti-Sm with 
the other patient antisera on the other hand is quantified in 
Figs. 7 and 8. For each Y 12 speckle its percent overlap with 
a  speckle  (or  speckles) generated  by  a  certain  serum  was 
calculated.  The  distribution  of the  speckles  into  different 
overlap categories was then plotted. The anti-Sm TA, anti- 
RNP  sera,  CL,  RE,  and  AL  have  most  of their  speckles 
clustered around 80-100% overlap (Fig. 7). The controls (Fig. 
8) with one exception show the opposite distribution:  Most 
speckles are found in the 0% overlap region. The La antiserum 
HA  gives  a  slightly  different  distribution:  Like  the  other 
control sera it has no speckles in the high overlap region, but 
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Figure  7.  Degree of overlap between immunofluorescence patterns 
generated by a mouse anti-Sm monoclonal and human anti-Sm and 
anti-RNP antisera. For each speckle generated by the monoclonal 
the degree of overlap with a  human Sm or RNP speckle was deter- 
mined as described in Materials and Methods (and by Hallman, H., 
U. Nyman, I. Pettersson, G. Sharp, and N. R. Ringertz, manuscript 
in preparation). On the X-axis the percentage of overlap is divided 
into ten percentiles with zero being no overlap of the two immuno- 
fuorescence patterns and  100% being complete agreement. The Y- 
axis represents the proportions of speckles in each percentile to the 
number of speckles investigated (number in parentheses). Four to six 
nuclei were examined for each pair of antisera. IS], TA human anti- 
Sm (129); ©, CL human anti-RNP (108); B, RE human anti-RNP 
( 146); O, AL human anti-RNP (132). 
~25% of the speckles are found in the intermediate overlap, 
30-50% category. This parallels the observation that La sera 
immunoprecipitate U1  snRNPs to some extent (Fig.  1 and 
reference  19). Thus partial  overlap can  also  be recognized 
with this method. 
Discussion 
In the present study we have attempted to analyze if certain 
nuclear antigens are located in the same nuclear region, within 
the resolving power of light microscopy. To achieve this we 
have  combined  the  use  of well-characterized antisera  and 
computer-aided image analysis. 
Examination  of the  double  immunofluorescence images 
reported  here  showed  that  the  pattern  obtained  with  the 
mouse and the human Sm antibodies in one and the same 
cell and in the same focal plane is almost identical (Fig.  7). 
The identity is perfect if the comparison is restricted to the 
larger speckles. The fact that not all the small speckles coincide 
may be due to limitations in the technique as one approaches 
limits set by the wavelength of light or to imperfections in the 
alignment of the FITC and TRITC images relative to each 
other. As pointed out in the Results section, the immunoflu- 
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Figure 8.  Degree of overlap between immunofluorescence patterns 
generated by mouse anti-Sm and anti-DNA monoclonals and hu- 
man autoantisera. The curves were generated as described in Fig.  7. 
[], PE human anti-Scl-70 overlap with mouse anti-Sm monoclonal 
(112); II, LU human anti-centromere overlap with mouse anti-Sm 
monoclonal (159); 0, HA human anti-La overlap with mouse anti- 
Sm monoclonal ( 122); ~7 mouse anti-DNA monoclonai overlap with 
human anti-Sm TA (133). 
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anti-RNP sera overlaps with the monoclonal Sm pattern to 
the  same  extent  as  the  patient  Sm  sera.  Hypothetically it 
would be possible to obtain fluorescent speckles consisting of 
a pure Sm-antigen, a pure RNP-antigen, or a combination. 
The results show that all speckles, as far as can be judged, 
contain the RNP-antigen and nothing indicates that any Sin- 
antigenic complexes, i.e,  U2, U4, U5, and U6 snRNPs, are 
located outside the RNP antigenic speckles: Naturally the Sm- 
antigenicity could mirror the sole presence of the U1 snRNP. 
However, to consider the possible interpretations the number 
of each snRNP in the cell nucleus must be taken into account. 
Estimations done by Ro-Choi and Busch (28), concerning the 
amount of snRNA,  results in the following fgures: U1  and 
U2  snRNAs are present  at  H1  X  106  copies each,  per cell 
nucleus,  U5  and  U6  snRNA  at  ~1  x  105  copies  per  cell 
nucleus.  All  snRNA  molecules  are  present  complexed  to 
proteins,  indicating  that  the  number  of  snRNP  particles 
should equal the number of snRNAs (18). 
Therefore it is unlikely that co-localizing speckles, on the 
one  hand  visualized  by  antibodies  specific  to  an  antigen 
common to all snRNPs and on the other hand visualized by 
antibodies specific for U 1 snRNP antigens, should reflect only 
the presence of the U 1 snRNP in situ. Eventually the question 
whether all speckles in  the  fluorescence pattern contain  all 
snRNP  antigens,  i.e.,  all speckles harbor U l,  U2,  U4,  US, 
and U6 snRNP or just UI snRNPs and some number of the 
other  snRNPs  cannot  be  settled  from  these  studies.  The 
presence of speckles without U 1 snRNPs is, however, ruled 
out by the overlap in patterns. 
The La immunofluorescence pattern is quite different from 
that produced by the Sm/RNP antibodies.  Still,  as demon- 
strated in Fig.  8, there is a partial overlap between the two. 
Although the La antigen is primarily associated with  RNA 
polymerase III transcripts (10,  27),  the results of Madore et 
ai. (19) support the finding of an overlap by showing that La 
antisera immunoprecipitate U 1 snRNPs. This is also observed 
in  the  La immunoprecipitate in  Fig.  1.  Objections can  be 
raised to  these  results,  claiming the  presence of anti-RNP 
antibodies in the La antiserum. However, Madore et al. (19) 
showed by using a  La antigen free cell  system that the  U1 
snRNP precipitation depends on the anti-La specificity. 
Comparisons  of the  Sm  and  RNP  immunofluorescence 
patterns with some other non-Sm/RNP specificities did not 
result in  co-localization. A  monoclonal  DNA antibody de- 
tected epitopes concentrated along the nuclear periphery, a 
region that normally is occupied by dense heterochromatin. 
If  anything, the anti-DNA immunofluorescence of the central 
portion of the nucleus showed an inverse relationship to the 
speckles detected with Sm/RNP antisera (image not shown). 
Neither did the  speckles detected with  the  LU, anticentro- 
meric, or the PE, anti Scl-70, antisera show any co-localization 
with Sm and RNP epitopes. The nonoverlap is clearly dem- 
onstrated in the plots of Fig. 8, but is not so readily appreciated 
by a  look on the immunofluorescence patterns (Figs.  5 and 
6). 
The use of the double immunofluorescence technique com- 
bined  with  digital  image analyses has  made  it  possible  to 
compare the distribution of different Sm/RNP antigens with 
considerable precision. The results so far, indicating that all 
the different snRNPs are present in the same nuclear regions, 
together with the fact that the La antigen co-localizes to some 
extent with the Sm/RNP complex, is of  interest in the analysis 
of the intranuclear organization. It will be of great interest to 
compare the localization of  these antigens with other antigens, 
such  as  the  cap-antigen  or  RNA  polymerases II  and  III, 
associated with transcriptional activity. 
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